Andrew J. Gawron
No Rating Available
(Learn About Our Rating System)

Andrew J. Gawron, MD, PhD

Languages spoken: English

Clinical Locations

University of Utah Hospital

Gastroenterology Endoscopy Center
Salt Lake City
801-213-9797

Veterans Administration Medical Center

Salt Lake City
801-584-1236

  • Dr. Andrew Gawron is an Associate Professor at the University of Utah and VA Medical Center. His clinical interests include treating patients with esophageal disease (gastroesophageal reflux disease, motility disorders such as achalasia, and eosinophilic esophagitis). He performs colonoscopy, upper endoscopy and interprets esophageal motility and pH studies.


    Dr. Gawron completed his medical degree, internal medicine residency, and gastroenterology fellowship as chief fellow at Northwestern University in Chicago, IL. He received additional experience in diagnosing and treating esophageal disorders at Northwestern University where he served as a Clinical Instructor.
    Dr. Gawron is board certified in Internal Medicine and Gastroenterology. He is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the International Society for Diseases of the Esophagus.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Gastroenterology)

  • Dr. Andrew Gawron is an Associate Professor at the University of Utah and VA Medical Center. His clinical interests include treating patients with esophageal disease (gastroesophageal reflux disease, motility disorders such as achalasia, and eosinophilic esophagitis). He performs colonoscopy, upper endoscopy and interprets esophageal motility and pH studies.


    Dr. Gawron completed his medical degree, internal medicine residency, and gastroenterology fellowship as chief fellow at Northwestern University in Chicago, IL. He received additional experience in diagnosing and treating esophageal disorders at Northwestern University where he served as a Clinical Instructor.
    Dr. Gawron is board certified in Internal Medicine and Gastroenterology. He is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the International Society for Diseases of the Esophagus.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Sub: Gastroenterology)

    Education history

    Fellowship Northwestern University Feinberg School of Medicine Chief Fellow
    Graduate Training Health Services and Outcomes Research - Northwestern University Feinberg School of Medicine M.S.
    Research Fellow Northwestern University Postdoctoral Research Fellow
    Fellowship Gastroenterology, Hepatology, and Nutrition - McGaw Medical Center Fellow
    Residency Internal Medicine - McGaw Medical Center Resident
    Professional Medical Medicine - Northwestern University Feinberg School of Medicine M.D.
    Research Fellow University of Nebraska Medical Center Postdoctoral Research Fellow
    Doctoral Training Pharmaceutical Chemistry - University of Kansas Ph.D.
    Graduate Training Pharmaceutical Chemistry - University of Kansas M.S.
    Undergraduate Chemistry, English minor - Truman State University B.S.

    Selected Publications

    Journal Article

    1. Shah I, Gawron AJ, Byrne KR, Inadomi JM (2024). Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities. Gastroenterology, 166(4), 549-552. (Read full article)
    2. Toy G, Colletier K, Hale G, Valentine J, Gawron AJ, Sossenheimer M, Peterson K, Aparicio R, Fang JC (2023). Incidence of retained biopsy specimens after esophagogastroduodenoscopy and colonoscopy. Endosc Int Open, 11(7), E653-E659. (Read full article)
    3. Robertson DJ, Dominitz JA, Beed A, Boardman KD, Del Curto BJ, Guarino PD, Imperiale TF, LaCasse A, Larson MF, Gupta S, Lieberman D, Planeta B, Shaukat A, Sultan S, Menees SB, Saini SD, Schoenfeld P, Goebel S, von Rosenvinge EC, Baffy G, Halasz I, Pedrosa MC, Kahng LS, Cassim R, Greer KB, Kinnard MF, Bhatt DB, Dunbar KB, Harford WV Jr, Mengshol JA, Olson JE, Patel SG, Antaki F, Fisher DA, Sullivan BA, Lenza C, Prajapati DN, Wong H, Beyth R, Lieb JG 2nd, Manlolo J, Ona FV, Cole RA, Khalaf N, Kahi CJ, Kohli DR, Rai T, Sharma P, Anastasiou J, Hagedorn C, Fernando RS, Jackson CS, Jamal MM, Lee RH, Merchant F, May FP, Pisegna JR, Omer E, Parajuli D, Said A, Nguyen TD, Tombazzi CR, Feldman PA, Jacob L, Koppelman RN, Lehenbauer KP, Desai DS, Madhoun MF, Tierney WM, Ho MQ, Hockman HJ, Lopez C, Carter Paulson E, Tobi M, Pinillos HL, Young M, Ho NC, Mascarenhas R, Promrat K, Mutha PR, Pandak WM Jr, Shah T, Schubert M, Pancotto FS, Gawron AJ, Underwood AE, Ho SB, Magno-Pagatzaurtundua P, Toro DH, Beymer CH, Kaz AM, Elwing J, Gill JA, Goldsmith SF, Yao MD, Protiva P, Pohl H, Kyriakides T, CONFIRM Study Group (2023). Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial. JAMA Netw Open, 6(7), e2321730. (Read full article)
    4. Joo YY, Pacheco JA, Thompson WK, Rasmussen-Torvik LJ, Rasmussen LV, Lin FTJ, Andrade M, Borthwick KM, Bottinger E, Cagan A, Carrell DS, Denny JC, Ellis SB, Gottesman O, Linneman JG, Pathak J, Peissig PL, Shang N, Tromp G, Veerappan A, Smith ME, Chisholm RL, Gawron AJ, Hayes MG, Kho AN (2023). Multi-ancestry genome- and phenome-wide association studies of diverticular disease in electronic health records with natural language processing enriched phenotyping algorithm. PLoS One, 18(5), e0283553. (Read full article)
    5. Benson R, Winterton C, Winn M, Krick B, Liu M, Abu-El-Rub N, Conway M, Del Fiol G, Gawron A, Hardikar S (2024). Leveraging Natural Language Processing to Extract Features of Colorectal Polyps From Pathology Reports for Epidemiologic Study. JCO Clin Cancer Inform, 7, e2200131. (Read full article)
    6. Gupta S, Earles A, Bustamante R, Patterson OV, Gawron AJ, Kaltenbach TR, Yassin H, Lamm M, Shah SC, Saini SD, Fisher DA, Martinez ME, Messer K, Demb J, Liu L (2022). Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy. Clin Gastroenterol Hepatol. (Read full article)
    7. Trivedi M, Godil S, Demb J, Earles A, Bustamante R, Patterson OV, Gawron A, Kaltenbach T, Mahata S, Liu L, Gupta S (2022). Baseline Characteristics and Longitudinal Outcomes of Traditional Serrated Adenomas: A Cohort Study. Clin Gastroenterol Hepatol. (Read full article)
    8. Trivedi M, Godil S, Demb J, Earles A, Bustamante R, Patterson OV, Gawron A, Kaltenbach T, Mahata S, Liu L, Gupta S (2022). Baseline characteristics and longitudinal outcomes of traditional serrated adenomas: a cohort study. Clin Gastroenterol Hepatol. (Read full article)
    9. Demb J, Liu L, Bustamante R, Dominitz JA, Earles A, Shah SC, Gawron AJ, Martinez ME, Gupta S (2022). COVID-19 Pandemic Had Minimal Impact on Colonoscopy Completion After Colorectal Cancer Red Flag Sign or Symptoms in US Veterans. Dig Dis Sci. (Read full article)
    10. Parbhu SK, Shah SC, Sossenheimer MJ, Fang JC, Peterson KA, Gawron AJ (2022). Index diagnoses of gastric intestinal metaplasia in the United States: patient characteristics, endoscopic findings, and clinical practice patterns at a large tertiary care center. Therap Adv Gastroenterol, 15, 17562848221117640. (Read full article)
    11. Gawron AJ, Sultan S, Glorioso TJ, Califano S, Kralovic SM, Jones M, Kirsh S, Dominitz JA (2022). Pre-endoscopy coronavirus disease 2019 screening and severe acute respiratory syndrome coronavirus-2 nucleic acid amplification testing in the Veterans Affairs healthcare system: clinical practice patterns, outcomes, and relationship to procedure volume. Gastrointest Endosc, 96(3), 423-432.e7. (Read full article)
    12. Yadlapati R, Gawron AJ, Gyawali CP, Chen J, Clarke J, Fass R, Jain A, Lynch K, Khan A, Katz PO, Katzka DA, Richter J, Schnoll-Sussman F, Spechler SJ, Vaezi MF, Vela M, Pandolfino JE (2022). Clinical role of ambulatory reflux monitoring in PPI non-responders: Recommendation statements. Aliment Pharmacol Ther. (Read full article)
    13. Gawron AJ, Sultan S, Glorioso TJ, Califano S, Kralovic SM, Jones M, Kirsh S, Dominitz JA (2022). Pre-Endoscopy COVID-19 screening and SARS-CoV-2 nucleic acid amplification testing in the VA Healthcare System: Clinical practice patterns, outcomes, and relationship to procedure volume. Gastrointest Endosc, 96(3), 423-432.e7. (Read full article)
    14. Keswani RN, Wood M, Benson M, Gawron AJ, Kahi C, Kaltenbach T, Yadlapati R, Gregory D, Duloy A (2022). Individualized feedback on colonoscopy skills improves group colonoscopy quality in providers with lower adenoma detection rates. Endosc Int Open, 10(3), E232-E237. (Read full article)
    15. Gawron AJ, Yao Y, Gupta S, Cole G, Whooley MA, Dominitz JA, Kaltenbach T (2020). Simplifying Measurement of Adenoma Detection Rates for Colonoscopy. Dig Dis Sci, 66(9), 3149-3155. (Read full article)
    16. Kaltenbach T, Gawron A, Meyer CS, Gupta S, Shergill A, Dominitz JA, Soetikno RM, Nguyen-Vu T, A Whooley M, Kahi CJ (2021). Adenoma Detection Rate (ADR) Irrespective of Indication Is Comparable to Screening ADR: Implications for Quality Monitoring. Clin Gastroenterol Hepatol, 19(9), 1883-1889.e1. (Read full article)
    17. Keswani RN, Kahi CJ, Benson M, Gawron AJ, Kaltenbach TR, Yadlapati RH, Gregory DL, Duloy A (2021). Cecal retroflexion is infrequently performed in routine practice and the retroflexed view is of poor quality. BMC Gastroenterol, 21(1), 307. (Read full article)
    18. McKenzie P, Fang J, Davis J, Qiu Y, Zhang Y, Adler DG, Gawron AJ (2020). Safety of endoscopist-directed nurse-administered balanced propofol sedation in patients with severe systemic disease (ASA class III). Gastrointest Endosc, 94(1), 124-130. (Read full article)
    19. Gawron AJ, Staub J, Bielefeldt K (2020). Impact of Health Insurance, Poverty, and Comorbidities on Colorectal Cancer Screening: Insights from the Medical Expenditure Panel Survey. Dig Dis Sci, 66(1), 70-77. (Read full article)
    20. Derek P, Jessica J, Brian S, Shoabo P, Wei C, Jorge R, Andrew G, Joshua B, Jeffrey C, Vicki S, David W, Jessica W (2020). P022 Utilization Patterns of Infliximab Originator to Infliximab Biosimilar in US Veterans. Am J Gastroenterol, 115(Suppl 1), S6. (Read full article)
    21. Gawron AJ, Kaltenbach T, Dominitz JA (2020). The Impact of the Coronavirus Disease-19 Pandemic on Access to Endoscopy Procedures in the VA Healthcare System. Gastroenterology, 159(4), 1216-1220.e1. (Read full article)
    22. DeLay K, Pandolfino JE, Gyawali CP, Frye J, Kaizer A, Menard-Katcher P, Sloan JA, Gawron AJ, Peterson K, Carlson DA, Khan A, Keswani RN, Yadlapati R (2020). Esophageal Manometry Competency Program Improves Gastroenterology Fellow Performance in Motility Interpretation. Am J Gastroenterol, 115(9), 1453-1459. (Read full article)
    23. Low EE, Demb J, Liu L, Earles A, Bustamante R, Williams CD, Provenzale D, Kaltenbach T, Gawron AJ, Martinez ME, Gupta S (2020). Risk Factors for Early-Onset Colorectal Cancer. Gastroenterology, 159(2), 492-501.e7. (Read full article)
    24. Gawron AJ, Bell R, Abu Dayyeh BK, Buckley FP, Chang K, Dunst CM, Edmundowicz SA, Jobe B, Lipham JC, Lister D, Canto MI, Smith MS, Starpoli AA, Triadafilopoulos G, Watson TJ, Wilson E, Pandolfino JE, Kaizer A, Van De Voorde Z, Yadlapati R (2020). Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel. Gastrointest Endosc, 92(1), 78-87.e2. (Read full article)
    25. Shah SC, Gawron AJ, Li D (2020). Surveillance of Gastric Intestinal Metaplasia. Am J Gastroenterol, 115(5), 641-644. (Read full article)
    26. Keswani RN, Benson M, Beveridge C, Gawron AJ, Gluskin AB, Kahi CJ, Kaltenbach TR, McClure J, Schenck R, Yadlapati RH, Duloy A (2019). Colonoscopy-Naïve Raters Can Be Trained to Assess Colonoscopy Quality. Clin Gastroenterol Hepatol, 18(4), 989-991.e1. (Read full article)
    27. Altayar O, Davitkov P, Shah SC, Gawron AJ, Morgan DR, Turner K, Mustafa RA (2019). AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Gastroenterology, 158(3), 732-744.e16. (Read full article)
    28. Davitkov P, Altayar O, Shah SC, Gawron AJ, Mustafa RA, Sultan S, Morgan DR (2019). Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations. Gastroenterology, 158(3), 751-759. (Read full article)
    29. Shah SC, Gawron AJ, Mustafa RA, Piazuelo MB (2019). Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. Gastroenterology, 158(3), 745-750. (Read full article)
    30. Shah SC, Gupta S, Li D, Morgan D, Mustafa RA, Gawron AJ (2020). Spotlight: Gastric Intestinal Metaplasia. Gastroenterology, 158(3), 704. (Read full article)
    31. Demb J, Yaseyyedi A, Liu L, Bustamante R, Earles A, Ghosh P, Gutkind JS, Gawron AJ, Kaltenbach TR, Martinez ME, Gupta S (2019). Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes. Clin Transl Gastroenterol, 10(11), e00092. (Read full article)
    32. Bustamante R, Earles A, Murphy JD, Bryant AK, Patterson OV, Gawron AJ, Kaltenbach T, Whooley MA, Fisher DA, Saini SD, Gupta S, Liu L (2019). Ascertainment of Aspirin Exposure Using Structured and Unstructured Large-scale Electronic Health Record Data. Med Care, 57(10), e60-e64. (Read full article)
    33. Gawron A, Bielefeldt K (2019). Unrelated Death After Colorectal Cancer Screening: Implications for Improving Colonoscopy Referrals. Fed Pract, 36(6), 262-270. (Read full article)
    34. McVay TR, Garrett G C, Celena B P, Klaus B, Fang JC, Chapman WW, Samore MH, Gawron AJ (2019). Natural Language Processing Accurately Identifies Dysphagia Indications for Esophagogastroduodenoscopy Procedures in a Large US Integrated Healthcare System: Implications for Classifying Overuse and Quality Measurement. AMIA Jt Summits Transl Sci Proc, 2019, 665-671. (Read full article)
    35. Patel J, Fang J, Taylor LJ, Adler DG, Gawron AJ (2019). Safety and efficacy of non-anesthesiologist administration of propofol sedation during esophagogastroduodenoscopy in the intensive care unit. Endosc Int Open, 7(4), E625-E629. (Read full article)
    36. Earles A, Liu L, Bustamante R, Coke P, Lynch J, Messer K, Martnez ME, Murphy JD, Williams CD, Fisher DA, Provenzale DT, Gawron AJ, Kaltenbach T, Gupta S (2019). Structured Approach for Evaluating Strategies for Cancer Ascertainment Using Large-Scale Electronic Health Record Data. JCO Clin Cancer Inform, 2, 1-12. (Read full article)
    37. Gawron AJ, Lawrence P, Millar MM, Dominitz JA, Gupta S, Whooley M, Kaltenbach T (2019). A Nationwide Survey and Needs Assessment of Colonoscopy Quality Assurance Programs in the VA. Fed Pract, 35(3), 26-32. (Read full article)
    38. Balbale S, Gawron A, LaVela SL (2019). Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy. Patient Exp J, 5(3), 149-159. (Read full article)
    39. Gawron AJ, Pandolfino JE, Howden CE (2014). Initial proton pump inhibitor prescription characteristics associated with long-term use in US Veterans diagnosed with gastroesophageal reflux disease. J Pharm Health Serv Res, 5(3), 157-164.

    Review

    1. Gawron AJ, Shah SC, Altayar O, Davitkov P, Morgan D, Turner K, Mustafa RA (2019). AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes. [Review]. Gastroenterology, 158(3), 705-731.e5. (Read full article)

    Editorial

    1. Shah I, Gawron AJ, Byrne KR, Inadomi JM (2024). Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities. Clin Gastroenterol Hepatol, 22(4), 679-683. (Read full article)
    2. Yadlapati R, Gawron AJ, Pandolfino JE (2022). Editorial: wireless pH-monitoring - is it time to put away the pH-impredance catheters: Authors' response. Aliment Pharmacol Ther, 56(8), 1298-1299. (Read full article)
    3. Gawron AJ, Dominitz JA (2022). Higher Quality Colonoscopy: Worth the Wait? Clin Transl Gastroenterol, 13(4), e00471. (Read full article)

  • News & Podcasts

    News

    Podcasts